APO Research
Talk to an analyst

APO RESEARCH · REPORT

Osimertinib Mesylate Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Osimertinib Mesylate Tablets Industry Growth and Trends Forecast to 2032

27 December 202596 pages

Choose your research edition.

Industry ResearchOsimertinib Mesylate Tablets Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Osimertinib Mesylate Tablets Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Osimertinib Mesylate Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Osimertinib Mesylate Tablets Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Osimertinib Mesylate Tablets Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Osimertinib Mesylate Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Osimertinib Mesylate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Osimertinib Mesylate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Osimertinib Mesylate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Osimertinib Mesylate Tablets include Wanbang Biopharmaceuticals, AstraZeneca, Zydus, Pharmacil, General Pharmaceuticals, Drug International and Beacon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Osimertinib Mesylate Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Osimertinib Mesylate Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Osimertinib Mesylate Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Osimertinib Mesylate Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Osimertinib Mesylate Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Osimertinib Mesylate Tablets Market by Company

Wanbang Biopharmaceuticals

AstraZeneca

Zydus

Pharmacil

General Pharmaceuticals

Drug International

Beacon

Osimertinib Mesylate Tablets Segment by Type

Original Drug

Generic Drug

Osimertinib Mesylate Tablets Segment by Application

Retail Pharmacies

Hospital and Clinic

Other

Osimertinib Mesylate Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Osimertinib Mesylate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Osimertinib Mesylate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Osimertinib Mesylate Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Osimertinib Mesylate Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Osimertinib Mesylate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Original Drug Table 2. Major Company of Generic Drug Table 3. Global Osimertinib Mesylate Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Osimertinib Mesylate Tablets Sales by Type (2021-2026) & (K Units) Table 5. Global Osimertinib Mesylate Tablets Sales Market Share in Volume by Type (2021-2026) Table 6. Global Osimertinib Mesylate Tablets Sales by Type (2021-2026) & (US$ Million) Table 7. Global Osimertinib Mesylate Tablets Sales Market Share in Value by Type (2021-2026) Table 8. Global Osimertinib Mesylate Tablets Price by Type (2021-2026) & (US$/Unit) Table 9. Global Osimertinib Mesylate Tablets Sales by Type (2027-2032) & (K Units) Table 10. Global Osimertinib Mesylate Tablets Sales Market Share in Volume by Type (2027-2032) Table 11. Global Osimertinib Mesylate Tablets Sales by Type (2027-2032) & (US$ Million) Table 12. Global Osimertinib Mesylate Tablets Sales Market Share in Value by Type (2027-2032) Table 13. Global Osimertinib Mesylate Tablets Price by Type (2027-2032) & (US$/Unit) Table 14. North America Osimertinib Mesylate Tablets Sales by Type (2021-2026) & (K Units) Table 15. North America Osimertinib Mesylate Tablets Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Osimertinib Mesylate Tablets Sales by Type (2021-2026) & (K Units) Table 17. Europe Osimertinib Mesylate Tablets Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Osimertinib Mesylate Tablets Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Osimertinib Mesylate Tablets Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Osimertinib Mesylate Tablets Sales by Type (2021-2026) & (K Units) Table 21. Latin America Osimertinib Mesylate Tablets Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Osimertinib Mesylate Tablets Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Osimertinib Mesylate Tablets Sales by Type (2021-2026) & (US$ Million) Table 24. Osimertinib Mesylate Tablets Industry Trends Table 25. Osimertinib Mesylate Tablets Industry Drivers Table 26. Osimertinib Mesylate Tablets Industry Opportunities and Challenges Table 27. Osimertinib Mesylate Tablets Industry Restraints Table 28. Global Osimertinib Mesylate Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Osimertinib Mesylate Tablets Revenue Market Share by Company (2021-2026) Table 30. Global Osimertinib Mesylate Tablets Sales by Company (2021-2026) & (K Units) Table 31. Global Osimertinib Mesylate Tablets Sales Share by Company (2021-2026) Table 32. Global Osimertinib Mesylate Tablets Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Osimertinib Mesylate Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Osimertinib Mesylate Tablets Major Company Production Sites and Headquarters Table 35. Global Osimertinib Mesylate Tablets Company, Product Type & Application Table 36. Global Osimertinib Mesylate Tablets Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Osimertinib Mesylate Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Osimertinib Mesylate Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Osimertinib Mesylate Tablets Sales by Region (2021-2026) & (K Units) Table 41. Global Osimertinib Mesylate Tablets Sales Market Share in Volume by Region (2021-2026) Table 42. Global Osimertinib Mesylate Tablets Sales by Region (2021-2026) & (US$ Million) Table 43. Global Osimertinib Mesylate Tablets Sales Market Share in Value by Region (2021-2026) Table 44. Global Osimertinib Mesylate Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Osimertinib Mesylate Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Osimertinib Mesylate Tablets Sales Market Share in Volume by Region (2027-2032) Table 47. Global Osimertinib Mesylate Tablets Sales by Region (2027-2032) & (US$ Million) Table 48. Global Osimertinib Mesylate Tablets Sales Market Share in Value by Region (2027-2032) Table 49. Global Osimertinib Mesylate Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Osimertinib Mesylate Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Osimertinib Mesylate Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Osimertinib Mesylate Tablets Sales Market Share in Volume by Application (2021-2026) Table 53. Global Osimertinib Mesylate Tablets Sales by Application (2021-2026) & (US$ Million) Table 54. Global Osimertinib Mesylate Tablets Sales Market Share in Value by Application (2021-2026) Table 55. Global Osimertinib Mesylate Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Osimertinib Mesylate Tablets Sales by Application (2027-2032) & (K Units) Table 57. Global Osimertinib Mesylate Tablets Sales Market Share in Volume by Application (2027-2032) Table 58. Global Osimertinib Mesylate Tablets Sales by Application (2027-2032) & (US$ Million) Table 59. Global Osimertinib Mesylate Tablets Sales Market Share in Value by Application (2027-2032) Table 60. Global Osimertinib Mesylate Tablets Price by Application (2027-2032) & (US$/Unit) Table 61. North America Osimertinib Mesylate Tablets Sales by Application (2021-2026) & (K Units) Table 62. North America Osimertinib Mesylate Tablets Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Osimertinib Mesylate Tablets Sales by Application (2021-2026) & (K Units) Table 64. Europe Osimertinib Mesylate Tablets Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Osimertinib Mesylate Tablets Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Osimertinib Mesylate Tablets Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Osimertinib Mesylate Tablets Sales by Application (2021-2026) & (K Units) Table 68. Latin America Osimertinib Mesylate Tablets Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Osimertinib Mesylate Tablets Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Osimertinib Mesylate Tablets Sales by Application (2021-2026) & (US$ Million) Table 71. Wanbang Biopharmaceuticals Company Information Table 72. Wanbang Biopharmaceuticals Business Overview Table 73. Wanbang Biopharmaceuticals Osimertinib Mesylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Wanbang Biopharmaceuticals Osimertinib Mesylate Tablets Product Portfolio Table 75. Wanbang Biopharmaceuticals Recent Development Table 76. AstraZeneca Company Information Table 77. AstraZeneca Business Overview Table 78. AstraZeneca Osimertinib Mesylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. AstraZeneca Osimertinib Mesylate Tablets Product Portfolio Table 80. AstraZeneca Recent Development Table 81. Zydus Company Information Table 82. Zydus Business Overview Table 83. Zydus Osimertinib Mesylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Zydus Osimertinib Mesylate Tablets Product Portfolio Table 85. Zydus Recent Development Table 86. Pharmacil Company Information Table 87. Pharmacil Business Overview Table 88. Pharmacil Osimertinib Mesylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Pharmacil Osimertinib Mesylate Tablets Product Portfolio Table 90. Pharmacil Recent Development Table 91. General Pharmaceuticals Company Information Table 92. General Pharmaceuticals Business Overview Table 93. General Pharmaceuticals Osimertinib Mesylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. General Pharmaceuticals Osimertinib Mesylate Tablets Product Portfolio Table 95. General Pharmaceuticals Recent Development Table 96. Drug International Company Information Table 97. Drug International Business Overview Table 98. Drug International Osimertinib Mesylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Drug International Osimertinib Mesylate Tablets Product Portfolio Table 100. Drug International Recent Development Table 101. Beacon Company Information Table 102. Beacon Business Overview Table 103. Beacon Osimertinib Mesylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Beacon Osimertinib Mesylate Tablets Product Portfolio Table 105. Beacon Recent Development Table 106. North America Osimertinib Mesylate Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. North America Osimertinib Mesylate Tablets Sales by Country (2021-2026) & (K Units) Table 108. North America Osimertinib Mesylate Tablets Sales Market Share by Country (2021-2026) Table 109. North America Osimertinib Mesylate Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 110. North America Osimertinib Mesylate Tablets Sales Market Share Forecast by Country (2027-2032) Table 111. North America Osimertinib Mesylate Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Osimertinib Mesylate Tablets Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Osimertinib Mesylate Tablets Market Share by Country (2021-2026) Table 114. North America Osimertinib Mesylate Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Osimertinib Mesylate Tablets Market Share Forecast by Country (2027-2032) Table 116. Europe Osimertinib Mesylate Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Europe Osimertinib Mesylate Tablets Sales by Country (2021-2026) & (K Units) Table 118. Europe Osimertinib Mesylate Tablets Sales Market Share by Country (2021-2026) Table 119. Europe Osimertinib Mesylate Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 120. Europe Osimertinib Mesylate Tablets Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Osimertinib Mesylate Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Osimertinib Mesylate Tablets Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Osimertinib Mesylate Tablets Market Share by Country (2021-2026) Table 124. Europe Osimertinib Mesylate Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Osimertinib Mesylate Tablets Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Osimertinib Mesylate Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Osimertinib Mesylate Tablets Sales by Country (2021-2026) & (K Units) Table 128. Asia-Pacific Osimertinib Mesylate Tablets Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Osimertinib Mesylate Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 130. Asia-Pacific Osimertinib Mesylate Tablets Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Osimertinib Mesylate Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Osimertinib Mesylate Tablets Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Osimertinib Mesylate Tablets Market Share by Country (2021-2026) Table 134. Asia-Pacific Osimertinib Mesylate Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Osimertinib Mesylate Tablets Market Share Forecast by Country (2027-2032) Table 136. Latin America Osimertinib Mesylate Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Latin America Osimertinib Mesylate Tablets Sales by Country (2021-2026) & (K Units) Table 138. Latin America Osimertinib Mesylate Tablets Sales Market Share by Country (2021-2026) Table 139. Latin America Osimertinib Mesylate Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 140. Latin America Osimertinib Mesylate Tablets Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Osimertinib Mesylate Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Osimertinib Mesylate Tablets Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Osimertinib Mesylate Tablets Market Share by Country (2021-2026) Table 144. Latin America Osimertinib Mesylate Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Osimertinib Mesylate Tablets Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Osimertinib Mesylate Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Osimertinib Mesylate Tablets Sales by Country (2021-2026) & (K Units) Table 148. Middle East and Africa Osimertinib Mesylate Tablets Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Osimertinib Mesylate Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 150. Middle East and Africa Osimertinib Mesylate Tablets Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Osimertinib Mesylate Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Osimertinib Mesylate Tablets Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Osimertinib Mesylate Tablets Market Share by Country (2021-2026) Table 154. Middle East and Africa Osimertinib Mesylate Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Osimertinib Mesylate Tablets Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Osimertinib Mesylate Tablets Distributors List Table 159. Osimertinib Mesylate Tablets Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Osimertinib Mesylate Tablets Image Figure 2. Global Osimertinib Mesylate Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Osimertinib Mesylate Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Osimertinib Mesylate Tablets Sales (2021-2032) & (K Units) Figure 5. Original Drug Image Figure 6. Global Original Drug Sales YoY Growth (2021-2032) & (K Units) Figure 7. Generic Drug Image Figure 8. Global Generic Drug Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Osimertinib Mesylate Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Osimertinib Mesylate Tablets Market Share by Type 2025 VS 2032 Figure 11. North America Osimertinib Mesylate Tablets Sales Market Share in Volume by Type in 2025 Figure 12. North America Osimertinib Mesylate Tablets Sales Market Share in Value by Type in 2025 Figure 13. Europe Osimertinib Mesylate Tablets Sales Market Share in Volume by Type in 2025 Figure 14. Europe Osimertinib Mesylate Tablets Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Osimertinib Mesylate Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Osimertinib Mesylate Tablets Sales Market Share in Value by Type in 2025 Figure 17. Latin America Osimertinib Mesylate Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Osimertinib Mesylate Tablets Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Osimertinib Mesylate Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Osimertinib Mesylate Tablets Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Osimertinib Mesylate Tablets Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Retail Pharmacies Image Figure 24. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 25. Hospital and Clinic Image Figure 26. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Osimertinib Mesylate Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Osimertinib Mesylate Tablets Market Share by Application 2025 VS 2032 Figure 31. North America Osimertinib Mesylate Tablets Sales Market Share in Volume by Application in 2025 Figure 32. North America Osimertinib Mesylate Tablets Sales Market Share in Value by Application in 2025 Figure 33. Europe Osimertinib Mesylate Tablets Sales Market Share in Volume by Application in 2025 Figure 34. Europe Osimertinib Mesylate Tablets Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Osimertinib Mesylate Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Osimertinib Mesylate Tablets Sales Market Share in Value by Application in 2025 Figure 37. Latin America Osimertinib Mesylate Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Osimertinib Mesylate Tablets Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Osimertinib Mesylate Tablets Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Osimertinib Mesylate Tablets Sales Market Share in Value by Application in 2025 Figure 41. North America Osimertinib Mesylate Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Osimertinib Mesylate Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Osimertinib Mesylate Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Osimertinib Mesylate Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Osimertinib Mesylate Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Osimertinib Mesylate Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Osimertinib Mesylate Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Osimertinib Mesylate Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Osimertinib Mesylate Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Osimertinib Mesylate Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Osimertinib Mesylate Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Osimertinib Mesylate Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Osimertinib Mesylate Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Osimertinib Mesylate Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Osimertinib Mesylate Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Osimertinib Mesylate Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Osimertinib Mesylate Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Osimertinib Mesylate Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Osimertinib Mesylate Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Osimertinib Mesylate Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Osimertinib Mesylate Tablets Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Osimertinib Mesylate Tablets Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Retail Pharmacies
  • Hospital and Clinic
  • Other
Companies covered
  • Wanbang Biopharmaceuticals
  • AstraZeneca
  • Zydus
  • Pharmacil
  • General Pharmaceuticals
  • Drug International
  • Beacon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Osimertinib Mesylate Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Osimertinib Mesylate Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Osimertinib Mesylate Tablets Market by Type
  6. 1.3.1 Original Drug
  7. 1.3.2 Generic Drug
  8. 1.4 Global Osimertinib Mesylate Tablets Market Size by Type
  9. 1.4.1 Global Osimertinib Mesylate Tablets Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Osimertinib Mesylate Tablets Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Osimertinib Mesylate Tablets Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Osimertinib Mesylate Tablets Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Osimertinib Mesylate Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Osimertinib Mesylate Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Osimertinib Mesylate Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Osimertinib Mesylate Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Osimertinib Mesylate Tablets Industry Trends
  2. 2.2 Osimertinib Mesylate Tablets Industry Drivers
  3. 2.3 Osimertinib Mesylate Tablets Industry Opportunities and Challenges
  4. 2.4 Osimertinib Mesylate Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Osimertinib Mesylate Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Osimertinib Mesylate Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Osimertinib Mesylate Tablets Price (2021-2026)
  4. 3.4 Global Osimertinib Mesylate Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Osimertinib Mesylate Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Osimertinib Mesylate Tablets Company, Product Type & Application
  7. 3.7 Global Osimertinib Mesylate Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Osimertinib Mesylate Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Osimertinib Mesylate Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Osimertinib Mesylate Tablets Tier 1, Tier 2, and Tier 3
4 Osimertinib Mesylate Tablets Regional Status and Outlook
  1. 4.1 Global Osimertinib Mesylate Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Osimertinib Mesylate Tablets Historic Market Size by Region
  3. 4.2.1 Global Osimertinib Mesylate Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Osimertinib Mesylate Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Osimertinib Mesylate Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Osimertinib Mesylate Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Osimertinib Mesylate Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Osimertinib Mesylate Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Osimertinib Mesylate Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Osimertinib Mesylate Tablets by Application
  1. 5.1 Osimertinib Mesylate Tablets Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Hospital and Clinic
  4. 5.1.3 Other
  5. 5.2 Global Osimertinib Mesylate Tablets Market Size by Application
  6. 5.2.1 Global Osimertinib Mesylate Tablets Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Osimertinib Mesylate Tablets Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Osimertinib Mesylate Tablets Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Osimertinib Mesylate Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Osimertinib Mesylate Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Osimertinib Mesylate Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Osimertinib Mesylate Tablets Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Osimertinib Mesylate Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Wanbang Biopharmaceuticals
  2. 6.1.1 Wanbang Biopharmaceuticals Company Information
  3. 6.1.2 Wanbang Biopharmaceuticals Business Overview
  4. 6.1.3 Wanbang Biopharmaceuticals Osimertinib Mesylate Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Wanbang Biopharmaceuticals Osimertinib Mesylate Tablets Product Portfolio
  6. 6.1.5 Wanbang Biopharmaceuticals Recent Developments
  7. 6.2 AstraZeneca
  8. 6.2.1 AstraZeneca Company Information
  9. 6.2.2 AstraZeneca Business Overview
  10. 6.2.3 AstraZeneca Osimertinib Mesylate Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AstraZeneca Osimertinib Mesylate Tablets Product Portfolio
  12. 6.2.5 AstraZeneca Recent Developments
  13. 6.3 Zydus
  14. 6.3.1 Zydus Company Information
  15. 6.3.2 Zydus Business Overview
  16. 6.3.3 Zydus Osimertinib Mesylate Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Zydus Osimertinib Mesylate Tablets Product Portfolio
  18. 6.3.5 Zydus Recent Developments
  19. 6.4 Pharmacil
  20. 6.4.1 Pharmacil Company Information
  21. 6.4.2 Pharmacil Business Overview
  22. 6.4.3 Pharmacil Osimertinib Mesylate Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pharmacil Osimertinib Mesylate Tablets Product Portfolio
  24. 6.4.5 Pharmacil Recent Developments
  25. 6.5 General Pharmaceuticals
  26. 6.5.1 General Pharmaceuticals Company Information
  27. 6.5.2 General Pharmaceuticals Business Overview
  28. 6.5.3 General Pharmaceuticals Osimertinib Mesylate Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 General Pharmaceuticals Osimertinib Mesylate Tablets Product Portfolio
  30. 6.5.5 General Pharmaceuticals Recent Developments
  31. 6.6 Drug International
  32. 6.6.1 Drug International Company Information
  33. 6.6.2 Drug International Business Overview
  34. 6.6.3 Drug International Osimertinib Mesylate Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Drug International Osimertinib Mesylate Tablets Product Portfolio
  36. 6.6.5 Drug International Recent Developments
  37. 6.7 Beacon
  38. 6.7.1 Beacon Company Information
  39. 6.7.2 Beacon Business Overview
  40. 6.7.3 Beacon Osimertinib Mesylate Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Beacon Osimertinib Mesylate Tablets Product Portfolio
  42. 6.7.5 Beacon Recent Developments
7 North America by Country
  1. 7.1 North America Osimertinib Mesylate Tablets Sales by Country
  2. 7.1.1 North America Osimertinib Mesylate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Osimertinib Mesylate Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Osimertinib Mesylate Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Osimertinib Mesylate Tablets Market Size by Country
  6. 7.2.1 North America Osimertinib Mesylate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Osimertinib Mesylate Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Osimertinib Mesylate Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Osimertinib Mesylate Tablets Sales by Country
  2. 8.1.1 Europe Osimertinib Mesylate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Osimertinib Mesylate Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Osimertinib Mesylate Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Osimertinib Mesylate Tablets Market Size by Country
  6. 8.2.1 Europe Osimertinib Mesylate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Osimertinib Mesylate Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Osimertinib Mesylate Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Osimertinib Mesylate Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Osimertinib Mesylate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Osimertinib Mesylate Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Osimertinib Mesylate Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Osimertinib Mesylate Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Osimertinib Mesylate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Osimertinib Mesylate Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Osimertinib Mesylate Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Osimertinib Mesylate Tablets Sales by Country
  2. 10.1.1 South America Osimertinib Mesylate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Osimertinib Mesylate Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Osimertinib Mesylate Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Osimertinib Mesylate Tablets Market Size by Country
  6. 10.2.1 South America Osimertinib Mesylate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Osimertinib Mesylate Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Osimertinib Mesylate Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Osimertinib Mesylate Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Osimertinib Mesylate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Osimertinib Mesylate Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Osimertinib Mesylate Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Osimertinib Mesylate Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Osimertinib Mesylate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Osimertinib Mesylate Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Osimertinib Mesylate Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Osimertinib Mesylate Tablets Value Chain Analysis
  2. 12.1.1 Osimertinib Mesylate Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Osimertinib Mesylate Tablets Production Mode & Process
  7. 12.2 Osimertinib Mesylate Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Osimertinib Mesylate Tablets Distributors
  10. 12.2.3 Osimertinib Mesylate Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst